The purpose of this study is to find a potential new treatment for Amyotrophic Lateral Sclerosis (ALS). You may remember this medical condition from the ice bucket challenge.

2 nights
5 visits

ALS is an untreatable, progressive, neurodegenerative (degeneration of the nervous system) disease specifically affecting both upper and lower motor neurons. While there are some treatments that can slightly delay the disease, there is an unmet need for more efficient treatment options. For this stage of the study, we are looking for healthy participants with no medical conditions, so we can understand how the medication is metabolised in a single dose. At a later stage, this treatment would be tested with people who have ALS.

This clinical trial has been approved by an independent ethics committee, and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!


Biological Sex Healthy males and females of non-childbearing potential (post-menopausal or surgically sterile)
Age 18 - 55 years old
BMI 18 - 32 kg/m²
Weight > 50 kg
Medications Not taking any
Medical History Nothing significant
Smoking History Non smokers or occasional smokers (no more than 2 cigarettes per week)